Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have signed a written consent form agreeing to take part in the trial
- People who are enrolled in the French Social Security system
- People who have breast cancer or a digestive (gut-related) cancer, and whose doctor is considering treating them with a type of chemotherapy called a fluoropyrimidine
- OR people who are on dialysis, meaning their kidneys are no longer working well enough on their own and a machine is helping filter their blood
- OR people who are patients under kidney specialist (nephrology) care with a specific condition referred to as "IR" (confirm with trial site)
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose blood count shows a low level of haemoglobin (below 8.5 g/dl), which means they have significant anaemia (low red blood cells)
- People whose blood test shows a substance called LDH at a level more than twice the upper limit of normal
- People who do not have full legal capacity to make their own decisions, or whose legal capacity is limited
- People who do not have health insurance
- People who are currently in the exclusion period of another research study, or who are listed in a national registry that prevents participation in trials (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
DPD Activity measurement in blood; Uracilemia in plasma; uracilemia-based DPD activity measurement; assessment of renal function using eGFR; sex; Age; creatininemia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.